ORIC Pharmaceuticals, Inc. (ORIC) Stock News & Chart | StockAdder

(ORIC)

ORIC Pharmaceuticals, Inc.

Stock chart and latest news for ORIC Pharmaceuticals, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

ORIC Pharmaceuticals, Inc. News

PRO

What's Behind The Drop In Oric Pharmaceuticals Stock Today?

Apr 2, 2026 simplywall.st

A Look At ORIC Pharmaceuticals (ORIC) Valuation After Positive Phase 1b Rinzimetostat Trial Update

Apr 13, 2026 Investor's Business Daily

Oric Pharma Misses The 'Best-In-Class' Boat Vs. Pfizer — And Plunges

Apr 1, 2026 Fierce Biotech

Oric chases Pfizer into phase 3 hailing prostate cancer edge, but investors send stock down

Apr 1, 2026 National Today

Oric Pharmaceuticals Stock Rises 6.5%, Analysts Maintain Buy Ratings

Apr 9, 2026 GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Apr 3, 2026 Investing.com

Wolfe Research reiterates Peerperform on ORIC Pharmaceuticals stock

Apr 1, 2026 Stock Titan

ORIC gives new employee 80,000 stock options and 15,000 RSUs

Apr 3, 2026 Seeking Alpha

ORIC Pharmaceuticals: Updates Did Not Bode Well For This Valuation (NASDAQ:ORIC)

Apr 1, 2026 MarketBeat

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Rating of "Moderate Buy" from Brokerages

Apr 7, 2026 simplywall.st

Why ORIC Pharmaceuticals (ORIC) Is Up 14.2% After Advancing Rinzimetostat Combo Into Phase 3 Trial

Apr 11, 2026 Investing.com

ORIC Pharmaceuticals stock tumbles 27% after trial update